跳至主要内容
临床试验/NCT00600639
NCT00600639终止4 期

Non-Invasive Mechanical Ventilation in Elderly Patients Affected by Acute Hypercapnic Respiratory Failure:A Randomized Control Study vs Standard Medical Therapy A Multicentric Randomized Controlled Trial

IRCCS Azienda Ospedaliero-Universitaria di Bologna1 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2004年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
82
试验地点
1
主要终点
Meet the criteria for INTUBATION: pH < 7.2 or pH < 7.25 in two consecutive occasions or worsening pH during NIV or rapid increase of 20mmHg of PaCO2 from baseline or PaO2< 50mmHg with FiO2 40% or Kelly score > 4 Mortality rate

研究概览

简要总结

The efficacy of NIMV to treat HARF has been widely demonstrated. However, in most of the studies performed in ICUs and in another facilities the mean age of the patients is usually less than 70 years.

A multicentric, randomized-controlled trial conduced in a group of "ELDERLY" patients with the mean age higher than 76 years, to compare the use of NIMV with Standard Medical Treatment (SMT) in the treatment of an episode of Acute Hypercapnic Respiratory Failure.

详细描述

Non-invasive mechanical ventilation (NIMV) has been successfully used in Hypercapnic Acute Respiratory Failure (HARF) since endotracheal intubation (ETI) and invasive ventilation are associated to high morbidity and mortality rate.

because of the lack of beds in most Intensive Care Units (ICUs) and the high mortality and cost associated with the increased of age, the "Elderly" patients affected by ARF due to chronic diseases are not always considered for ETI.

The efficacy of NIMV to treat HARF has been widely demonstrated. However, in most of the studies performed in ICUs and in another facilities the mean age of the patients is usually less than 70 years (see tab1).

Authors MEAN AGE

(yrs) TYPE of STUDY

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
76 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age higher 75 years old
  • Hypercapnic acute respiratory failure (PaCO2 greater 50 mmHg and pH lower than 7.35)
  • Respiratory rate (RR) higher 25 bpm after 12 hours of standard medical therapy.

排除标准

  • Respiratory failure due to pulmonary oedema
  • Kelly's score equal or higher than 4
  • Cardio-respiratory arrest
  • Systolic arterial blood pressure greater than 90 mmHg or severe arrhythmia
  • Recent facial, oesophageal and gastric surgery

研究组 & 干预措施

1

Experimental

non-invasive ventilation with BiPAP Vision or another ICU ventilator with NIV option

干预措施: Non-invasive mechanical ventilation using a BiPAP Vision or any other ICU ventilators with NIV option (Device)

1

Experimental

non-invasive ventilation with BiPAP Vision or another ICU ventilator with NIV option

干预措施: standard medical therapy plus oxygen that includes salbutamol, prednisolone and antibiotics as needed (Drug)

2

Active Comparator

standard therapy + oxygen

干预措施: standard medical therapy that includes salbutamol, prednisolone and antibiotics as needed (Drug)

结局指标

主要结局

Meet the criteria for INTUBATION: pH < 7.2 or pH < 7.25 in two consecutive occasions or worsening pH during NIV or rapid increase of 20mmHg of PaCO2 from baseline or PaO2< 50mmHg with FiO2 40% or Kelly score > 4 Mortality rate

时间窗: 3 months

次要结局

  • Arterial Blood Gasses improvement Clinical improvement (decrease of respiratory rate and dyspnoea value) Length of Hospital stay(3 months)

研究者

研究点 (1)

Loading locations...

相似试验